chr14-100337027-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004184.4(WARS1):​c.1254+35T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.78 in 1,597,568 control chromosomes in the GnomAD database, including 488,003 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.75 ( 43680 hom., cov: 32)
Exomes 𝑓: 0.78 ( 444323 hom. )

Consequence

WARS1
NM_004184.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.00700

Publications

16 publications found
Variant links:
Genes affected
WARS1 (HGNC:12729): (tryptophanyl-tRNA synthetase 1) Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. Two forms of tryptophanyl-tRNA synthetase exist, a cytoplasmic form, named WARS, and a mitochondrial form, named WARS2. Tryptophanyl-tRNA synthetase (WARS) catalyzes the aminoacylation of tRNA(trp) with tryptophan and is induced by interferon. Tryptophanyl-tRNA synthetase belongs to the class I tRNA synthetase family. Four transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
WARS1 Gene-Disease associations (from GenCC):
  • distal hereditary motor neuropathy
    Inheritance: AD Classification: DEFINITIVE, LIMITED Submitted by: G2P, ClinGen
  • neuronopathy, distal hereditary motor, type 9
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Broad Center for Mendelian Genomics, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with microcephaly and speech delay, with or without brain abnormalities
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 14-100337027-A-G is Benign according to our data. Variant chr14-100337027-A-G is described in ClinVar as [Benign]. Clinvar id is 1252470.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.844 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WARS1NM_004184.4 linkc.1254+35T>C intron_variant Intron 10 of 10 ENST00000392882.7 NP_004175.2 P23381-1A0A024R6K8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WARS1ENST00000392882.7 linkc.1254+35T>C intron_variant Intron 10 of 10 1 NM_004184.4 ENSP00000376620.2 P23381-1

Frequencies

GnomAD3 genomes
AF:
0.753
AC:
114463
AN:
152026
Hom.:
43644
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.632
Gnomad AMI
AF:
0.693
Gnomad AMR
AF:
0.843
Gnomad ASJ
AF:
0.843
Gnomad EAS
AF:
0.865
Gnomad SAS
AF:
0.838
Gnomad FIN
AF:
0.812
Gnomad MID
AF:
0.769
Gnomad NFE
AF:
0.778
Gnomad OTH
AF:
0.785
GnomAD2 exomes
AF:
0.802
AC:
200767
AN:
250254
AF XY:
0.804
show subpopulations
Gnomad AFR exome
AF:
0.636
Gnomad AMR exome
AF:
0.878
Gnomad ASJ exome
AF:
0.835
Gnomad EAS exome
AF:
0.864
Gnomad FIN exome
AF:
0.814
Gnomad NFE exome
AF:
0.779
Gnomad OTH exome
AF:
0.807
GnomAD4 exome
AF:
0.783
AC:
1131525
AN:
1445424
Hom.:
444323
Cov.:
46
AF XY:
0.785
AC XY:
561592
AN XY:
715672
show subpopulations
African (AFR)
AF:
0.625
AC:
20763
AN:
33218
American (AMR)
AF:
0.872
AC:
38802
AN:
44502
Ashkenazi Jewish (ASJ)
AF:
0.837
AC:
21642
AN:
25868
East Asian (EAS)
AF:
0.879
AC:
34486
AN:
39252
South Asian (SAS)
AF:
0.835
AC:
71778
AN:
85954
European-Finnish (FIN)
AF:
0.816
AC:
43345
AN:
53128
Middle Eastern (MID)
AF:
0.820
AC:
4687
AN:
5716
European-Non Finnish (NFE)
AF:
0.773
AC:
849151
AN:
1098248
Other (OTH)
AF:
0.787
AC:
46871
AN:
59538
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
12038
24076
36115
48153
60191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20552
41104
61656
82208
102760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.753
AC:
114551
AN:
152144
Hom.:
43680
Cov.:
32
AF XY:
0.758
AC XY:
56337
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.632
AC:
26202
AN:
41484
American (AMR)
AF:
0.844
AC:
12904
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.843
AC:
2927
AN:
3472
East Asian (EAS)
AF:
0.866
AC:
4468
AN:
5162
South Asian (SAS)
AF:
0.837
AC:
4039
AN:
4824
European-Finnish (FIN)
AF:
0.812
AC:
8598
AN:
10592
Middle Eastern (MID)
AF:
0.786
AC:
231
AN:
294
European-Non Finnish (NFE)
AF:
0.778
AC:
52892
AN:
67998
Other (OTH)
AF:
0.786
AC:
1661
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1418
2836
4255
5673
7091
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
854
1708
2562
3416
4270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.775
Hom.:
14679
Bravo
AF:
0.750
Asia WGS
AF:
0.835
AC:
2906
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 16, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Neuronopathy, distal hereditary motor, type 9 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
1.6
DANN
Benign
0.59
PhyloP100
-0.0070
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2234530; hg19: chr14-100803364; API